• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Team

/ November 17, 2016

Aaron Davenport

Managing Director

Mr. Davenport plays a leading role in all aspects of the firm’s investment strategy and execution focusing on both the pharmaceuticals and specialty chemicals industries.  He currently serves as Chairman of the Board of Heubach, Seqens, Woodstock Sterile Solutions, Noramco, Extractas Bioscience and Purisys. He is also a member of the Board of Directors of Venator Materials PLC (NYSE: VNTR). He previously served as Chairman of the Board of Wavelength Pharmaceuticals, Perimeter Solutions, AEB Group, Halo Pharmaceutical and TriTex and a member of the Board of Directors of IBA Molecular and Archroma.

Prior to SK Capital, Mr. Davenport was a Principal at Arsenal Capital Partners where he co-led Arsenal’s healthcare investing efforts and served on the firm’s Operating and Investment Committees. Mr. Davenport’s professional career began in a general management role with CB Richard Ellis/Whittier Partners, where his leadership positions included Director of Business Strategy and Development.

Mr. Davenport was previously the Chairman of Charter Brokerage and previously served on the boards of Bend Research, IRIX Pharmaceuticals, Scientific Protein Laboratories, Priority Solutions, and Innovative Medical Device Solutions.

Mr. Davenport graduated magna cum laude with a B.A. in History from Amherst College and has an M.B.A. from the Tuck School of Business at Dartmouth College.

Primary Sidebar

  • Barry Siadat
  • Jamshid Keynejad
  • Jack Norris
  • Aaron Davenport
  • Mario Toukan
  • Barry Penney
  • Stephen d’Incelli
  • Ben Dillon
  • Jonathan Borell
  • Michael Gilbert
  • Richard Jackson
  • Simon Dowker
  • Jared Kramer
  • Dan Lory
  • Joshua Lieberman
  • Robert Abrams
  • Cole Abernathy
  • Santiago Nielsen
  • Booey Ghani
  • Julius O. Nestler
  • Michael Anagnos
  • Hannah McLaughlin
  • Anthony Marr
  • Scott Solomon
  • Matthew Gates
  • McKenzie Chu
  • Joshua Landsberg
  • Olivia Cargian
  • Sanjeet Raman
  • Alexander Jackson
  • Andrew Tabatabaei
  • Harman Gill
  • Christina Park
  • Chris Redding
  • David Mezzanotte
  • George Gregory
  • Randy Dearth
  • Daniele Ferrari
  • Kris Radhakrishnan
  • Anne Kolton
  • Amy Williams
  • Asim Bhatia
  • Brian Coe
  • Amber Shook
  • Jana Wayne
  • Jerry Truzzolino
  • James Gaven
  • Kate Ghirardi
  • Cecilia Pulmano
  • Susanne Clarke
  • Yoonsuk Han
  • Simone Slade
  • Christina He
  • Srinivas Sarnu
  • Sarvinoz Fahriddinova
  • Richa Kanani
  • Marco Testa
  • Rachael Estell
  • Luz Florez
  • Amanda Zhou
  • Jocelyn Chen
  • Mary Anne Plafcan
  • Caroline Mercado
  • Kathryn Coppa

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login